World-first laboratory study finds low-dose Naltrexone may improve ME/CFS symptoms

Griffith News
14 July 2021
https://news.griffith.edu.au/2021/07/14/world-first-laboratory-study-finds-low-dose-naltrexone-may-improve-me-cfs-symptoms/

Carrie Forrest, MBA, MPH (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Carrie takes LDN for an autoimmune thyroid disorder/thyroid cancer, PCOS, chronic fatigue, and migraines.

Sandy discussed her Chronic Epstein Barr Virus, CFS/ME and LDN Journey (LDN, low-dose Naltrexone) from LDN Research Trust on Vimeo.

Lori shares her story of LDN for ME/CFS (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Derek Enlander Talks about Low Dose Naltrexone LDN, CFS/ME 2021 (LDN) from LDN Research Trust on Vimeo.

Covid-19 Long Haulers

Pensum Regenerative Medicine
09 February 2021
https://www.pensummed.pro/blogs/covid-19-long-haulers

Low-Dose Naltrexone for Fibromyalgia and ME/CFS

Verywell Health
04 November 2020
https://www.verywellhealth.com/low-dose-naltrexone-ldn-for-fibromyalgia-cfs-716070

Low-Dose Naltrexone for Treating MS Symptoms

Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888

NutriChem's LDN Book Event with Dr. Yousuf Siddiqui (Low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Yousuf Siddiqui, B.Arch.Sci., N.D

Autoimmunity, The Thyroid, Low-dose Naltrexone (LDN) & Beyond

Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients

Front. Immunol
31 October 2019
https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/full